ABT-510

ABT-510 is an anti-angiogenic TSP peptide (Thrombospondin-1 analogue) that induces apoptosis and inhibits ovarian tumour growth in an orthotopic, syngeneic model of epithelial ovarian cancer. ABT-510 also reduces angiogenesis and inflammatory responses in a murine model of inflammatory bowel disease. ABT-510 can be used in studies of cancer (particularly epithelial ovarian cancer) and inflammatory bowel disease (IBD).
Read more
€0.00 (tax incl.)
Reference:
HY-13545
Product Details
HY-13545

Data sheet

Size
Multiple sizes
Reactivity
Apoptosis
Application
COVID-19-immunoregulation
CAS
251579-55-2

Menu

Settings